<DOC>
	<DOCNO>NCT02492373</DOCNO>
	<brief_summary>To investigate benefit application topical high potency steroid incidence post inflammatory hyperpigmentation laser treatment .</brief_summary>
	<brief_title>Topical Corticosteroids Incidence Postinflammatory Hyperpigmentation After QsNdYAG Laser</brief_title>
	<detailed_description>- The incidence post inflammatory hyperpigmentation ( PIH ) treat lentigines Q-switched Nd : YAG laser 78.3 % . - It find incidence PIH decrease 40 % applied topical high potency steroid 2 day laser treatment . - By anti-inflammatory anti-PIH effect high potency steroid , investigator aim application steroid 2 day 2 day laser treatment would better reduction incidence PIH Q-switched Nd : YAG laser .</detailed_description>
	<mesh_term>Lentigo</mesh_term>
	<mesh_term>Hyperpigmentation</mesh_term>
	<mesh_term>Clobetasol</mesh_term>
	<criteria>Having multiple lentigo side face Fitzpatrick skin phototype 35 Patients lesion clinical suspicion precancerous skin malignancy kind Patients photosensitive dermatosis Pregnancy lactation woman Patients wound infection ( herpes , ) day treatment Patients moderate severe inflammatory acne , Immunosuppressed patient , history vitiligo Patients unrealistic concerns/expectations inability appropriate postoperative care</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Post inflammatory hyperpigmentation</keyword>
	<keyword>topical high potency steroid</keyword>
	<keyword>Qs NdYAG laser</keyword>
</DOC>